SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 149 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 4.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $481,000 | -11.3% | 27,845 | +2.1% | 0.03% | -17.6% |
Q3 2015 | $542,000 | -53.2% | 27,267 | -61.3% | 0.03% | -45.2% |
Q2 2015 | $1,158,000 | +784.0% | 70,475 | +284.0% | 0.06% | +785.7% |
Q1 2014 | $131,000 | -36.1% | 18,352 | -15.9% | 0.01% | -36.4% |
Q4 2013 | $205,000 | +50.7% | 21,824 | 0.0% | 0.01% | +37.5% |
Q3 2013 | $136,000 | -5.6% | 21,824 | 0.0% | 0.01% | -11.1% |
Q2 2013 | $144,000 | – | 21,824 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 1,304,376 | $23,414,000 | 7.30% |
Kassirer Asset Management Corp | 291,784 | $5,238,000 | 5.39% |
First Trust Capital Management L.P. | 637,578 | $11,445,000 | 2.19% |
NEXTHERA CAPITAL LP | 510,486 | $9,163,000 | 1.69% |
HAVENS ADVISORS LLC | 100,000 | $1,795,000 | 1.35% |
Piermont Capital Management Inc. | 172,980 | $3,105,000 | 1.02% |
PRELUDE CAPITAL MANAGEMENT, LLC | 674,446 | $12,106,000 | 0.97% |
ALPINE ASSOCIATES MANAGEMENT INC. | 1,495,600 | $26,845,000 | 0.96% |
LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $3,590,000 | 0.87% |
BOOTHBAY FUND MANAGEMENT, LLC | 332,075 | $5,961,000 | 0.87% |